Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Part of the Patient Revolution: President and Chief of Research of Topical BioMedics, Inc., Lou Paradise Invited to Forbes Healthcare Summit
  • USA - English


News provided by

Topical BioMedics

Oct 09, 2013, 15:15 ET

Share this article

Share toX

Share this article

Share toX


Rhinebeck, NY (PRWEB) October 09, 2013 -- On October 9th and 10th in New York, Steve Forbes will host the second annual Forbes Healthcare Summit, to discuss how the newly empowered consumers will drive disruption and change.

The summit, titled Empowering The Patient Revolution, will highlight how key stakeholders can work together to generate actionable solutions and reform to organize and finance new systems and ultimately provide better outcomes for patients. Explains Forbes:

Topical BioMedics, Inc., is humbled to be a very dedicated part of the patient revolution

Post this

"The revolution in healthcare is being led by patients, who are now more empowered than ever -- demanding more choice and transparency and harnessing technology to garner the best information to weigh their options and be more in control of their care."

Topricin’s platform proudly speaks intelligently to the needs of millions of people who suffer with chronic and acute pain issues, requiring better options, along with making a viable, ethical contribution in discussing a sustainable healthcare model that includes all stakeholders. Says Mr. Paradise:

“Working closely with doctors and patients, Topical BioMedics sees and hears how patients are demanding credible, empowering information, transparency and better, and safer pain relief solutions so that individuals can begin to take charge of healthcare choices. Topical BioMedics, Inc is humbled to be a very dedicated part of the patient revolution, and Topricin has taken a leadership role by contributing with all other stakeholders to develop better solutions and new economic models that provide better outcomes for patients - where sustainability and profitability live side by side.”

Mr. Paradise admires Forbes for creating a space for leaders in the healthcare industry to come together with open-minds to help empower patients.    

“Honest discussion and debate can ultimately generate stronger understandings and alliances, and considering the nature of America’s overmedicated society, the patient cannot afford and certainly our country cannot afford another moment of narrow-minded thinking, entrenched positions or both,” says Paradise.

The Forbes’ Summit agenda is set with provocative and crucial topics. Key session titles include:

  • The Future Of Medicine: An Interview With Billionaire, Pharmaceutical Inventor, and Entrepreneur Patrick Soon-Shiong, Chairman and CEO, NantHealth
  • Consumers Driving Philanthropy In Healthcare: The traditional concept of philanthropy involved sending money and goods to those in need, but the outcomes were inconsistent. Now, many prominent foundations succeed because they promote personal accountability and allow patients to take control of their futures.

Closing remarks will be hosted by Steve Forbes, Chairman & Editor-in-Chief, Forbes Media.

About Topical BioMedics, Inc.: Topical BioMedics is a research and development leader in topical natural medicines for pain relief. The company’s product line includes original Topricin Pain Relief and Healing Cream, Topricin Foot Therapy Cream, and Topricin for Children. The natural formulas have been awarded a patent for the topical treatment of pain associated with fibromyalgia and neuropathy, and are safe for diabetics.

Topricin products are made in the U.S.A. and are in compliance with federal rules for homeopathic over-the-counter medicines. Topricin products are growing in popularity and are safe for diabetics and the entire family, including pregnant women. Topricin is also a lifestyle product that athletes and other active people appreciate for its ability to help with performance and recovery.

Topricin formulas contain: no parabens, petroleum or harsh chemicals, are odorless, greaseless and non-irritating, and produce no known side effects. Doctors and pharmacists can find more information about Topricin in the Physicians’ Desk Reference (PDR). http://www.Topricin.com

About Forbes Conferences: Forbes conferences bring the pages of Forbes magazine and the conversation of Forbes.com to life. They provide an experience of total immersion into our content, entrepreneurial spirit, prestigious community, and philosophy of business success through lifelong relationships. From panels led by our editors to one-on-one interviews with business and political visionaries, to unique networking opportunities, attendees are enveloped in the world of Forbes from the moment they register culminating in intellectual discourse of the highest caliber. This dialogue, taking place in elegant and interesting environments, is the essence of Forbes conferences.

Christina Towle, Topical BioMedics, http://www.topricin.com, (845) 871-4900 x1114, [email protected]

Modal title

Bringing together leaders from a wide spectrum of disciplines in the healthcare industry to discuss how the newly empowered consumers will drive disruption and change.
Bringing together leaders from a wide spectrum of disciplines in the healthcare industry to discuss how the newly empowered consumers will drive disruption and change.
Dr. Travis Stork
Dr. Travis Stork
Christy Turlington
Christy Turlington
"Honest discussion and debate can ultimately generate stronger understandings and alliances"
"Honest discussion and debate can ultimately generate stronger understandings and alliances"
Lou Paradise
Lou Paradise
Bringing together leaders from a wide spectrum of disciplines in the healthcare industry to discuss how the newly empowered consumers will drive disruption and change. Dr. Travis Stork Christy Turlington "Honest discussion and debate can ultimately generate stronger understandings and alliances" Lou Paradise

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.